1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Cancer Services
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/637
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCostello, Anthony-
dc.contributor.authorMurphy, Declan-
dc.date.accessioned2016-05-11T00:31:00Z-
dc.date.available2016-05-11T00:31:00Z-
dc.date.issued2010-07-
dc.identifier.citationMed J Aust. 2010 Jul 5;193(1):4-5.en_US
dc.identifier.issn0025-729Xen_US
dc.identifier.issn1326-5377en_US
dc.identifier.urihttp://hdl.handle.net/11434/637-
dc.description.abstractPSA testing may lead to overtreatment, but this should not rule out its judicious use as an early predictor of prostate cancer.en_US
dc.publisherAustralasian Medical Publishing Companyen_US
dc.subjectPSAen_US
dc.subjectProstate Specific Antigenen_US
dc.subjectProstate Canceren_US
dc.subjectPredictive Testsen_US
dc.subjectUrologyen_US
dc.subjectDirector of Urology, The Epworth Centreen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectAustralian Prostate Cancer Research Centre Epworth HealthCare, Melbourne, Victoria, Australiaen_US
dc.titleHas PSA testing truly been a "public health disaster"?: Replyen_US
dc.typeLetteren_US
dc.identifier.journaltitleThe Medical Journal of Australiaen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/20618104en_US
dc.description.affiliatesRoyal Melbourne Hospital, Melbourne, VIC.en_US
dc.description.affiliatesDepartment of Urological Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC.en_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
Epworth Prostate Centre
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.